Ergocalciferol and Prednisolone drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Ergocalciferol and Prednisolone. Common interactions include arthralgia among females and coronary artery disease among males.
The phase IV clinical study analyzes what interactions people who take Ergocalciferol and Prednisolone have. It is created by eHealthMe based on reports of 402 people who take Ergocalciferol and Prednisolone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
402 people who take Ergocalciferol and Prednisolone together, and have interactions are studied.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 23,359 Ergocalciferol users for its effectiveness, alternative drugs and more.
What is Prednisolone?
Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 182,030 Prednisolone users for its effectiveness, alternative drugs and more.
Number of Ergocalciferol and Prednisolone reports submitted per year:
Ergocalciferol and Prednisolone drug interactions by gender *:
Ergocalciferol and Prednisolone drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ergocalciferol and Prednisolone?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Alternative drugs to, pros and cons of the 2 drugs:
Common Ergocalciferol and Prednisolone interactions:
- Asthenia (weakness): 5 reports
- Lack of strength: 5 reports
- Lack of strength, muscle weakness, weakness: 5 reports
- Muscle fatigue (a condition in which muscles cannot exert their normal force): 5 reports
- Muscle weakness (a lack of muscle strength): 5 reports
- Muscular weakness (muscle weakness): 5 reports
- Pulmonary embolism (blockage of the main artery of the lung): 6 reports
- Pulmonary embolus (blockage of the lung artery by foreign matter or by a blood clot): 6 reports
- Weakness: 5 reports
Browse all drug interactions of Ergocalciferol and Prednisolone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Ergocalciferol interactions:
Browse all interactions between Ergocalciferol and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Prednisolone interactions:
Browse all interactions between Prednisolone and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol and prednisolone (the active ingredients of Ergocalciferol and Prednisolone, respectively), and Ergocalciferol and Prednisolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ergocalciferol and Prednisolone.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Truvada and Subarachnoid Haemorrhage - 18 seconds ago
- Lialda and Osteoporosis - 35 seconds ago
- Accutane and Pityriasis Lichenoides Et Varioliformis Acuta - 48 seconds ago
- Lomotil and Ascites - a minute ago
- Eszopiclone and Poor Quality Sleep - a minute ago
- Tamsulosin Hydrochloride and Photophobia Aggravated - a minute ago
- Gabapentin and Metastases To Nervous System - a minute ago
- Cataplexy and Urinary Retention - a minute ago
- Swelling and drugs of ingredients of pegvaliase-pqpz - a minute ago
- Lymecycline vs. Azithromycin - a minute ago